A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
I-Cheng LeeYa-Wen HungChien-An LiuRheun-Chuan LeeChien-Wei SuTeh-Ia HuoChung-Pin LiYee ChaoHan-Chieh LinMing-Chih HouYi-Hsiang HuangPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Albumin-bilirubin grade is an important factor associated with survival in BCLC stage B HCC patients undergoing TACE. ALBI-TAE model can be applied to select patients who can get most benefit from TACE.